Patents by Inventor Giulia Nigro

Giulia Nigro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLS
    Publication number: 20170296621
    Abstract: The present invention is directed to an agonist of NOD2 for use in therapy for increasing the autonomous capacity of survival of vertebrate adult stem cells, without loss of their capacity to multiply and differentiate, and preferably the capacity of survival of intestinal stem cells, especially in response to a stress. The invention also concerns the use of an agonist of Nod2 for increasing in vitro or ex vivo the autonomous capacity of survival, without loss of multiplication and differentiation capacity of mammalian adult stem cell. The invention also discloses different media and support for mammalian adult stem cells. The invention also concerns an in vitro screening process for identifying molecules capable increasing, in response to a stress, the autonomous capacity of survival, without loss of multiplication and differentiation capacity of mammalian adult stem cells.
    Type: Application
    Filed: April 3, 2017
    Publication date: October 19, 2017
    Inventors: Philippe Sansonetti, Giulia NIGRO
  • NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLS
    Publication number: 20150343018
    Abstract: The present invention is directed to an agonist of NOD2 for use in therapy for increasing the autonomous capacity of survival of vertebrate adult stem cells, without loss of their capacity to multiply and differentiate, and preferably the capacity of survival of intestinal stem cells, especially in response to a stress. The invention also concerns the use of an agonist of Nod2 for increasing in vitro or ex vivo the autonomous capacity of survival, without loss of multiplication and differentiation capacity of mammalian adult stem cell. The invention also discloses different media and support for mammalian adult stem cells. The invention also concerns an in vitro screening process for identifying molecules capable increasing, in response to a stress, the autonomous capacity of survival, without loss of multiplication and differentiation capacity of mammalian adult stem cells.
    Type: Application
    Filed: October 3, 2013
    Publication date: December 3, 2015
    Applicant: INSTITUT PASTEUR
    Inventors: Philippe Sansonetti, Giulia Nigro